← Back
$BCRX All transactions

BIOCRYST PHARMACEUTICALS INC

▼ SELL 10b5-1 Plan

$ Value

$1.4M

Shares

150,000

Price

$9

Filed

Mar 18

Insider

Name

Barnes Alane P

Title

Chief Legal Officer

CIK

0001584348

Roles

Officer

Transaction Details

Transaction Date

2026-03-16

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

400,703

Footnotes

This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person. | The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.95 to $9.57. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. | The option grant became exercisable at the rate of 25% on each of the first, second, third, and fourth anniversaries of the date of grant.

Filing Info

Accession No.

0000882796-26-000015

Form Type

4

Issuer CIK

0000882796

Barnes Alane P's History

Date Ticker Type Value
2026-03-16 BCRX M $826K
2026-03-16 BCRX $1.4M
2026-03-16 BCRX M $0
2025-12-22 BCRX $167K
2025-12-19 BCRX F $125K
2025-12-17 BCRX A $0
2025-12-17 BCRX A $0
2025-12-15 BCRX $162K
2025-12-12 BCRX F $65K
2025-12-03 BCRX $151K

Other Insiders at BCRX (90d)

Insider Bought Sold Last
MILANO VINCENT 2026-02-27
Stonehouse Jon P 2026-03-02
Frank Steven 2026-02-27
Barnes Alane P
Chief Legal Officer
2026-03-16
Milne Jill C. 2026-02-27
HEGGIE THERESA $505K 2026-03-20
McKee Amy E 2026-02-27
Menon Sandeep
Chief R&D Officer
2026-04-06